# FDA Inspection 1062451 - LifeShare Blood Centers - July 12, 2018

Source: https://www.keypedia.com/records/fda_inspections/lifeshare-blood-centers/4dc95361-c7a0-49e9-8db5-cf3e6cffa1b3
Source feed: FDA_Inspections

> FDA Inspection 1062451 for LifeShare Blood Centers on July 12, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1062451
- Company Name: LifeShare Blood Centers
- Inspection Date: 2018-07-12
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1194790 - 2022-12-08](https://www.keypedia.com/records/fda_inspections/lifeshare-blood-centers/adcd8113-88b0-4361-a74e-55b8583bb3f7)
- [FDA Inspection 1194790 - 2022-12-08](https://www.keypedia.com/records/fda_inspections/lifeshare-blood-centers/cda075a6-9a39-47e6-a3c2-180980c82ad6)
- [FDA Inspection 979829 - 2016-08-04](https://www.keypedia.com/records/fda_inspections/lifeshare-blood-centers/7778030f-9dfd-4a92-ac8f-3e1860ec2445)
- [FDA Inspection 865784 - 2014-02-06](https://www.keypedia.com/records/fda_inspections/lifeshare-blood-centers/0fccc384-4003-482e-9aff-fd1e6a7ee796)
- [FDA Inspection 773961 - 2012-03-15](https://www.keypedia.com/records/fda_inspections/lifeshare-blood-centers/3213badc-0d0e-423e-a3bd-f64b6a8721e4)

Company: https://www.keypedia.com/companies/lifeshare-blood-centers/0f104528-4d55-4b73-bfd5-84c9d9dd4272

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d